Dosimetric evaluation of radiation exposure during I-125 vicryl mesh implants: Implications for ACOSOG z4032

Annals of Surgical Oncology

Volumn 14, Issue 12, 2007, Pages 3610-3613

  Smith, Ryan P ^a   Schuchert, Matthew ^a   Komanduri, Krishna ^a   Burton, Steven ^a   Heron, Dwight E ^a   Luketich, James D ^a   D'Amato, Thomas ^b   Landreneau, Rodney ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Brachytherapy; Exposure; Lung Cancer; Radiation; Vicryl Mesh; Z4032

Indexed keywords

IODINE 125; POLYGLACTIN;

ARTICLE; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIODE; HAND; HEALTH CARE PERSONNEL; HUMAN; HUMAN TISSUE; IMPLANT; LUNG CANCER; MICRODOSIMETRY; ONCOLOGY; PHYSICIAN; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION EXPOSURE; SHOULDER; STAFF; SURGEON; THERMOLUMINESCENCE DOSIMETRY;

BRACHYTHERAPY; EVALUATION STUDIES AS TOPIC; FILM DOSIMETRY; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTRAOPERATIVE CARE; IODINE RADIOISOTOPES; LUNG NEOPLASMS; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; PHYSICIANS; POLYGLACTIN 910; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; RADIATION DOSAGE; RADIATION INJURIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 36349019701     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9624-0     Document Type: Article

References (9)

1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995; 60:615-22
2. Chen A, Galloway M, Landreneau R, et al. Intraoperative I125 brachytherapy for high-risk stage I non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys 1999; 44:1057-63
3. Santos R, Colonias A, Parda D, et al. Comparison between sublobar resection and I125 brachytherapy after sublobar resection in high-risk patients with Stage I non-small cell lung cancer. Surgery 2003; 134:691-7
4. 125I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer. Brachytherapy 2005; 4:278-85
5. Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg 1994; 107:1087-93
6. Okada M, Yoshikawa K, Hatta T, Tsubota N. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg 2001; 71:956-60
7. Charles M. UNSCEAR report 2000: sources and effects of ionizing radiation. United Nations Scientific Committee on the Effects of Atomic Radiation. J Radiol Prot 2001; 21:83-6
8. National Council on Radiation Protection and Measurements. Limitation of exposure to ionizing radiation. NCRP Report No. 116; 1993a
9. Khan FM. The physics of radiation therapy. Third Edition. Lippincott Williams & Wilkins, 2003